Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Durata Defibrillation ICD Lead

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$104,154

527 payments

Research payments

$0

0 payments

Through program year 2020, $104,154 in general payments and $0 in research payments were reported against Durata Defibrillation ICD Lead (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $27,617 241
2019 General $76,537 286

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $104,154 527 payments
Top recipients General payments · program year 2020
  1. Jesse Sethi Cardiovascular Disease · Phoenix, AZ $15,411 56% · 23 payments
  2. Murlidhar Amin Cardiovascular Disease · Port Arthur, TX $3,152 11% · 5 payments
  3. Mohammad Pashmforoush Cardiovascular Disease · Oceanside, CA $1,890 7% · 4 payments
  4. Samir Germanwala Cardiovascular Disease · Longview, TX $264 <1% · 3 payments
  5. David Dobrin Cardiovascular Disease · El Paso, TX $237 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Cardiovascular Disease Internal Medicine $23,948 87% · 69 practitioners
  2. Clinical Cardiac Electrophysiology Internal Medicine $1,772 6% · 58 practitioners
  3. Interventional Cardiology Internal Medicine $907 3% · 17 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $247 <1% · 7 practitioners
  5. Internal Medicine $243 <1% · 6 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Arizona $15,606 57% · 7 recipients
  2. Texas $5,444 20% · 34 recipients
  3. California $2,424 9% · 21 recipients
  4. New Jersey $1,969 7% · 19 recipients
  5. Florida $520 2% · 20 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

527 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record